Johnson & Johnson
http://www.jnj.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Johnson & Johnson
Stock Watch: Defeat Is The Mother Of Reinvention
Companies that are successful do not need to change their name, therapeutic area or product focus.
Big Pharma Companies Have Higher US FDA Approval Percentage Than Everybody Else
Almost 80% of novel agent submissions from the biggest companies were approved in recent years, compared with a 60% approval rate for the rest of the industry, according to a Pink Sheet analysis of FDA approval decisions since 2021.
Everything’s Coming Up Pfizer: The Biggest Of Pharma Firms Leads Industry In Pending Applications For US FDA Approval
Pfizer’s lineup of novel agents under review stands at seven, while no other big pharma has more than two novel candidates; Sanofi is tops in recent approvals since 2021, with seven novel agents cleared, but has no pending NMEs.
India Clinical Trials Scenario: Leaders From Novartis, IQVIA, PwC Signal Winds Of Change
Leaders from Novartis, IQVIA and PwC discuss the ground situation for trials in India as regulatory reforms, improved infrastructure and clinical expertise provide opportunities. Potential in areas like orphan diseases and tips for peer Amgen on getting trials going in India were among other highlights.
Company Information
- Industry
- In Vitro Diagnostics
- Medical Devices
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Abiomed, Inc.
- Acclarent Inc.
- Actelion Pharmaceuticals Ltd.
- AdvanceCOR GmbH
- ALZA Corporation
- Alios BioPharma, Inc.
- Animas Corporation
- Aragon Pharmaceuticals, Inc.
- Auris Health, Inc.
- Auris Surgical Robotics
- BeneVir Biopharm, Inc.
- BioMedical Enterprises, Inc.
- Biosense Webster, Inc.
- Calibra Medical, Inc.
- Centyrex Internal Venture
- Cilag AG
- Cerenovus
- Codman & Shurtleff, Inc
- Coherex Medical, Inc.
- Conor Medsystems, Inc.
- Cordis Webster, Inc.
- CorImmun GmbH
- Cougar Biotechnology, Inc.
- Covagen AG
- Crucell N.V.
- DePuy Mitek, Inc.
- DePuy Orthopaedics, Inc.
- DePuy Synthes, Inc.
- Ensure Medical
- Ethicon, Inc.
- FemRx Inc.
- Flexible Stenting Solutions, Inc.
- Gynecare, Inc.
- Hansen Medical, Inc.
- Innovative Surgical Solutions, LLC
- Interventional Spine, Inc.
- Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
- Janssen Diagnostics
- Janssen Pharmaceuticals
- Janssen Vaccines & Prevention B.V.
- JointPoint, Inc.
- LifeScan, Inc.
- Medical Enterprises Distribution, LLC
- Medos International SARL
- Megadyne Medical Products, Inc.
- Mentor Corporation
- Micrus Endovascular Corporation
- Molsaic Internal Venture
- Momenta Pharmaceuticals, Inc.
- NeoStrata Company, Inc.
- Neuravi Limited
- NeuWave Medical, Inc.
- Novira Therapeutics
- Omrix Biopharmaceuticals, Inc.
- Ortho Biotech Products, L.P.
- Ortho-McNeil, Inc.
- Orthotaxy
- Peninsula Pharmaceuticals, Inc.
- Pulsar Vascular Inc
- RespiVert Ltd.
- Scios, Inc.
- Selected Nerve Stimulation Internal Ventures
- Sentio, LLC
- Sequus Pharmaceuticals
- Stem Cell Internal Venture
- Synthes, Inc.
- Tibotec
- Torax Medical, Inc.
- Triage Medical, Inc.
- Verb Surgical Inc.
- Veridex
- Vigor Sub, Inc.
- Vistakon
- XO1 Limited
- TARIS Biomedical LLC
- Verb Surgical, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice